Time Until Loss to Follow-Up, Incidence, and Predictors Among Adults Taking ART at Public Hospitals in Southern Ethiopia

References

• The Ethiopian public health institute. HIV Related Estimates and Projections in Ethiopia for the Year 2019; 2020.
   Google Scholar
• May MT, Gompels M, Delpech V, et al. Impact on life expectancy of HIV-1 positive individuals of CD4R cell count and viral load response to antiretroviral therapy. AIDS. 2014;28(8):1193–1202. doi:10.1097/QAD.0000000000000243
   PubMed Web of Science ®Google Scholar
• WHO. US/HIV AIDS Report; 2015.
   Google Scholar
• Assemie MA, Muchie KF, Ayele TA. Incidence and predictors of loss to follow up among HIV‑infected adults at Pawi General Hospital, northwest Ethiopia: competing risk regression model. BMC Res Notes. 2018;11:287. doi:10.1186/s13104-018-3407-5
   Google Scholar
• WHO. HIV/AIDS Fact Sheets; 2019.
   Google Scholar
• UNAIDS. Global HIV & AIDS Statistics — 2019 Fact Sheet; 2019.
   Google Scholar
• Bekolo CE, Webster J, Batenganya M, Sume GE, Kollo B. Trends in mortality and loss to follow-up in HIV care at the Nkongsamba Regional hospital, Cameroon. BMC Res Notes. 2013;6(1):512. doi:10.1186/1756-0500-6-512
   PubMedGoogle Scholar
• Berheto TM, Haile DB, Mohammed S. Predictors of loss to follow-up in patients living with HIV/AIDS after initiation of antiretroviral therapy. North Am J Med Sci. 2014;6:453–459. doi:10.4103/1947-2714.141636
   PubMedGoogle Scholar
• Mekonnen N, Abdulkadir M, Shumetie E, Gebreegziabher AB, Kindie MY. Incidence and predictors of loss to follow‑up among HIV infected adults after initiation of first line anti‑retroviral therapy at University of Gondar comprehensive specialized Hospital Northwest Ethiopia, 2018: retrospective follow up study. BMC Res Notes. 2019;12:111. doi:10.1186/s13104-019-4154-y
   PubMed Web of Science ®Google Scholar
• Seifu W, Ali W, Meresa B. Predictors of loss to follow up among adult clients attending antiretroviral treatment at Karamara general hospital, Jigjiga town, Eastern Ethiopia, 2015: a retrospective cohort study. BMC Infect Dis. 2018;2018(1):280. doi:10.1186/s12879-018-3188-4
   Web of Science ®Google Scholar
• Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007;4(10):e298. doi:10.1371/journal.pmed.0040298
   PubMed Web of Science ®Google Scholar
• Leroy V, Malateste K, Rabie H, et al. Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration. J Acquir Immune Defic Syndr. 2013;62(2):208. doi:10.1097/QAI.0b013e31827b70bf
   Web of Science ®Google Scholar
• Melaku Z, Lulseged S, Wang C, et al. Outcomes among HIV‐infected children initiating HIV care and antiretroviral treatment in Ethiopia. Trop Med Int Health. 2017;22(4):474–484. doi:10.1111/tmi.12834
   PubMed Web of Science ®Google Scholar
• Li X, Margolick JB, Conover CS, et al. Interruption and Discontinuation of Highly Active Antiretroviral Therapy in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2005;38(3):320–328.
   PubMed Web of Science ®Google Scholar
• Teshale AB, Tsegaye AT, Wolde HF. Incidence and predictors of loss to follow up among adult HIV patients on antiretroviral therapy in University of Gondar Comprehensive Specialized Hospital: a competing risk regression modeling. PLoS One. 2020;15(1):e0227473. doi:10.1371/journal.pone.0227473
   PubMed Web of Science ®Google Scholar
• Estil J, Tweya H, Egger M, et al. Tracing of patients lost to follow-up and HIV transmission: mathematical modelling study based on two large ART programmes in Malawi. J Acquir Immune Defic Syndr. 2014;65(5):e179. doi:10.1097/QAI.0000000000000075
   Web of Science ®Google Scholar
• Taiwo B. Understanding transmitted HIV resistance through the experience in the USA. Int J Infect Dis. 2009;13(5):552–559. doi:10.1016/j.ijid.2008.10.008
   PubMed Web of Science ®Google Scholar
• Meloni TT, Chang CA, Eisen G, et al. Long-Term Outcomes on Antiretroviral Therapy in a Large Scale-Up Program in Nigeria. PLoS One. 2016;11(10):e0164030. doi:10.1371/journal.pone.0164030
   Web of Science ®Google Scholar
• Stephen BA, Michael K, Bosco B, Samson O, Winnie M. Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa. BMC Infect Dis. 2016;16:43.
   Web of Science ®Google Scholar
• Abebe M, Sileshi G, Tolosa E, et al. Predictors of loss to follow-up in antiretroviral treatment for adult patients in the Oromia region, Ethiopia. HIV/AIDS Res Palliat Care. 2016;8:83–92.
   Google Scholar
• Wubshet M, Berhane Y, Worku A, Kebede Y, Diro E. High Loss to Followup and Early Mortality Create Substantial Reduction in Patient Retention at Antiretroviral Treatment Program in North-West Ethiopia. Isrn Aids. 2012;2012:1–9. doi:10.5402/2012/721720
   Google Scholar
• Ayele W, Mulugeta A, Desta A, Rabito FA. Treatment outcomes and their determinants in HIV patients on Anti-retroviral Treatment Program in selected health facilities of Kembata and Hadiya zones, Southern Nations, Nationalities and Peoples Region, Ethiopia. BMC Public Health. 2015;15(1):1–13. doi:10.1186/s12889-015-2176-5
   Web of Science ®Google Scholar
• Tiruneh YM, Gala´rraga O, Genberg B, Wilson IB. Retention in care among HIV-infected adults in Ethiopia, 2005–2011: a mixed-methods study. PLoS One. 2016;11(6):2005–2011. doi:10.1371/journal.pone.0156619
   Web of Science ®Google Scholar
• Nuwagira E, Rhoda WM, Amir A. Predictors of Loss to Follow up among HIV Infected Patients Initiated on Second Line ART in Southwestern Uganda. HIV. 2018;3:2.
   Google Scholar
• Kelly C, Hulme C, Farragher T, Clarke G. Are differences in travel time or distance to healthcare for adults in global north countries associated with an impact on health outcomes? A systematic review. BMJ Open. 2016;6(11):e013059. doi:10.1136/bmjopen-2016-013059
   PubMed Web of Science ®Google Scholar
• Bilinski A, Birru E, Peckarsky M, et al. Distance to care, enrollment and loss to follow-up of HIV patients during decentralization of antiretroviral therapy in Neno District, Malawi: a retrospective cohort study. PLoS One. 2017;12(10):e0185699. doi:10.1371/journal.pone.0185699
   PubMed Web of Science ®Google Scholar
• Muluwas A, Girma T. Predictors of loss to follow up in patients living with HIV/AIDS after initiation of antiretroviral therapy in Benshangul Gumuz Regional State, Western Ethiopia. Int Invent Sci J. 2019;3:11.
   Google Scholar
• Geng EH, Bangsberg DR, Musinguzi N, et al. Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in africa through a sampling-based approach. J Acquir Immune Defic Syndr. 2010;53(3):405–411. doi:10.1097/QAI.0b013e3181b843f0
   PubMed Web of Science ®Google Scholar
• Assemie MA, Leshargie CT, Petrucka P. Outcomes and factors affecting mortality and successful tracing among patients lost to follow-up from antiretroviral therapy in Pawi Hospital, Northwest Ethiopia. Trop Med Health. 2019;47(1):52. doi:10.1186/s41182-019-0181-6
   Web of Science ®Google Scholar
• Zürcher K, Mooser A, Anderegg N, et al. Outcomes of HIV-10. Positive patients lost to follow-up in Africantreatment programmes. Trop Med Int Health. 2017;22(4):375–387. doi:10.1111/tmi.12843
   PubMed Web of Science ®Google Scholar
• Maskew M, MacPhail P, Menezez C, Rubel D. Lost to follow up-contributing factors and challenges in south African patients on antiretroviral therapy. South African Med j. 2007;97(9):853–857.
   PubMed Web of Science ®Google Scholar
• Agezew T, Abilo T, Derseh L, Yimer M. Incidence and Predictors of First Line Anti-Retroviral Therapy Failure among Adults Receiving HIV Care in North West Ethiopia: a Hospital-Based Follow-Up Study. J Infect Dis Epidemiol. 2019;5:072.
   Google Scholar
• Musa BM, Coker M, Bussell S, et al. Long-term outcomes of antiretroviral therapy in an adult HIV program: a 10-year retrospective cohort study in Kano, Nigeria. Ann Saudi Med. 2015;35(4):303–311. doi:10.5144/0256-4947.2015.303
   PubMed Web of Science ®Google Scholar
• Kazooba P, Mayanja BN, Levin J, Masiira B, Kaleebu P. Virological failure on first-line antiretroviral therapy; associated factors and a pragmatic approach for switching to second line therapy-evidence from a prospective cohort study in rural South-Western Uganda, 2004–2011. Pan Afric Med J. 2018;29:191.
   Web of Science ®Google Scholar
• Marshall CS, Curtis AJ, Spelman T, et al. Impact of HIV-associated conditions on mortality in people commencing anti-retroviral therapy in resource limited settings. PLoS One. 2013;8(7):e68445. doi:10.1371/journal.pone.0068445
   Web of Science ®Google Scholar
• Süttmann U, Ockenga J, Selberg O, Hoogestraat L, Deicher H, Müller MJ. Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J Acquir Immune Defic Syndr. 1995;8:239–246. doi:10.1097/00042560-199503010-00004
   Web of Science ®Google Scholar
• Beneri CA, Zeldow B, Nachman S, et al. Loss to follow-up among infants in a study of isoniazid prophylaxis (P1041) in South Africa. Int J Tuberc Lung Dis. 2013;17(1):32–38. doi:10.5588/ijtld.12.0282
   Web of Science ®Google Scholar
• Ayele HT, Mourik MS, Debray TP, Bonten MJ. Isoniazid prophylactic therapy for the prevention of tuberculosis in HIV infected adults: a systematic review and meta-analysis of randomized trials. PLoS One. 2015;10:e0142290. doi:10.1371/journal.pone.0142290
   PubMed Web of Science ®Google Scholar
• Lawn SD, Wood R, Cock KMD, Kranzer K, Lewis JJ, Churchyard GJ. Antiretrovirals and isoniazid preventive therapy in the prevention of HIV associated tuberculosis in settings with limited health-care resources. Lancet Infect Dis. 2010;10:489–498. doi:10.1016/S1473-3099(10)70078-5
   PubMed Web of Science ®Google Scholar
• Taraz S, Terefa BA, Samba N, et al. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2011;377(9777):1588–1598.
   Google Scholar
• Durovni B, Saraceni V, Moulton LH, et al. Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial. Lancet Infect Dis. 2013;13(10):852–858. doi:10.1016/S1473-3099(13)70187-7
   PubMed Web of Science ®Google Scholar
• Rachel A, Anthony PM, Sheela VS. Predictors of loss to follow-up among patients on ART at a rural hospital in KwaZulu-Natal, South Africa. PLoS One. 2017;12(5):e0177168. doi:10.1371/journal.pone.0177168
   Web of Science ®Google Scholar